ReviewExpert review of anticancer therapy2019
The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib.
Christopher P Wilding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papercites it